Unsuspected strongyloidiasis in hospitalised elderly patients with and without eosinophilia

Clinical Microbiology and Infection

Volumn 12, Issue 8, 2006, Pages 787-792

  Pirisi, Mario ^a   Salvador, E ^a   Bisoffi, Z ^b   Gobbo, M ^b   Smirne, C ^a   Gigli, C ^c   Minisini, R ^a   Fortina, G ^c   Bellomo, G ^a   Bartoli, E ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b S Cuore Hospital   (Italy)

^c MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

Diagnosis; Elderly patients; Eosinophilia; Occupational groups; Serology; Strongyloides stercoralis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IVERMECTIN; PARASITE ANTIBODY;

ADULT; AGED; AGRICULTURAL WORKER; ANAMNESIS; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EOSINOPHIL COUNT; EOSINOPHILIA; FECES CULTURE; FEMALE; GERIATRIC CARE; GERIATRIC PATIENT; HOSPITAL PATIENT; HUMAN; IMMUNOFLUORESCENCE TEST; INFECTION RISK; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SEROLOGY; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

STRONGYLOIDES; STRONGYLOIDES STERCORALIS;

EID: 33745620723     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01500.x     Document Type: Article

References (28)

1. Grove DI. Human strongyloidiasis. Adv Parasitol 1996; 38: 251-309.
2. Liu LX, Weller PF. Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am 1993; 7: 655-682.
3. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33: 1040-1047.
4. Mahmoud A. Intestinal nematodes (roundworms). In: Mandell GL, Bennet JE, Dolin R, eds, Mandell, Douglas and Bennett's principles and practice of infectious diseases, 5th edn. Philadelphia, PA: Churchill Livingstone, 2000; 2938-2943.
5. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004; 17: 208-217.
6. Anonymous. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000; 49 (RR-10): 1-125, CE121-127.
7. Genta RM. Global prevalence of strongyloidiasis: Critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 1989; 11: 755-767.
8. Genta RM, Gatti S, Linke MJ, Cevini C, Scaglia M. Endemic strongyloidiasis in northern Italy: Clinical and immunological aspects. Q J Med 1988; 68: 679-690.
9. Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ 2000; 320: 1468.
10. Altman DG, Bland JM. Diagnostic tests 3: Receiver operating characteristic plots. BMJ 1994; 309: 188.
11. Genta RM, Ottesen EA, Neva FA, Walzer PD, Tanowitz HB, Wittner M. Cellular responses in human strongyloidiasis. Am J Trop Med Hyg 1983; 32: 990-994.
12. Haque AK, Schnadig V, Rubin SA, Smith JH. Pathogenesis of human strongyloidiasis: Autopsy and quantitative parasitological analysis. Mod Pathol 1994; 7: 276-288.
13. Roman-Sanchez P, Pastor-Guzman A, Moreno-Guillen S, Igual-Adell R, Suner-Generoso S, Tornero-Estebanez C. High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries. Am J Trop Med Hyg 2003; 69: 336-340.
14. Berk SL, Verghese A, Alvarez S, Hall K, Smith B. Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med 1987; 147: 1257-1261.
15. Mahmoud AA. Strongyloidiasis. Clin Infect Dis 1996; 23: 949-952.
16. Davidson RA, Fletcher RH, Chapman LE. Risk factors for strongyloidiasis. A case-control study. Arch Intern Med 1984; 144: 321-324.
17. Brigden M, Graydon C. Eosinophilia detected by automated blood cell counting in ambulatory North American outpatients. Incidence and clinical significance. Arch Pathol Lab Med 1997; 121: 963-967.
18. Limaye AP, Abrams JS, Silver JE, Ottesen EA, Nutman TB. Regulation of parasite-induced eosinophilia: Selectively increased interleukin 5 production in helminth-infected patients. J Exp Med 1990; 172: 399-402.
19. Mahanty S, Abrams JS, Limaye AP, Nutman TB. Linkage of interleukin-4 and interleukin-5 production in human helminth infections. Trans Assoc Am Physicians 1991; 104: 296-303.
20. Krause JR, Boggs DR. Search for eosinopenia in hospitalized patients with normal blood leukocyte concentration. Am J Hematol 1987; 24: 55-63.
21. Winkel P, Statland BE, Saunders AM, Osborn H, Kupperman H. Within-day physiologic variation of leukocyte types in healthy subjects as assayed by two automated leukocyte differential analyzers. Am J Clin Pathol 1981; 75: 693-700.
22. Moqbel R, Becker AB. The human eosinophil. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, eds, Wintrobe's clinical hematology, 10th edn. Baltimore, MD: Williams & Wilkins 1999; 351-361.
23. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338: 1592-1600.
24. Rothstein G. Disordered hematopoiesis and myelodysplasia in the elderly. J Am Geriatr Soc 2003; 51 (suppl 3): S22-S26.
25. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002; 66: 749-752.
26. Conway DJ, Atkins NS, Lillywhite JE et al. Immunodiagnosis of Strongyloides stercoralis infection: A method for increasing the specificity of the indirect ELISA. Trans R Soc Trop Med Hyg 1993; 87: 173-176.
27. Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994; 169: 1076-1079.
28. Marti H, Haji HJ, Savioli L et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 1996; 55: 477-481.